Aug 22, 2021
Is there a common set of key risk indicators (KRIs) the clinical trials industry is monitoring to achieve world-class Risk-Based Quality Management (RBQM)? That’s one of the key issues explored during Linda Sullivan’s interview with two returning CTO guests: Artem Andrianov, CEO of Cyntegrity and Johann Proeve,...
Aug 10, 2021
Centralized monitoring clinical trial programs can catch outlying data points in almost real time and quickly notify the clinical trial study team. That’s one of the key takeaways from Crupa Kurien’s interview with Linda Sullivan, MBA, Executive Director of WCG’s Metric Champion Consortium. Kurien is the central...